Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Benzodiazepine addiction is real. This physician shares his story.

David Mokotoff, MD
Meds
July 24, 2016
Share
Tweet
Share

Say the words, “drug addiction,” and most of us think of heroin, alcohol, cocaine, or opiates. However, lurking in the shadows is a less talked about epidemic: addiction to benzodiazepines, commonly known as “benzos.” I should know because after taking a nighttime dose of lorazepam (Ativan) for about ten years; I finally weaned myself off this and all other prescription sleep medications.

About twelve years ago, my father died and then my dog. But that was nothing in comparison to the fight to save my marriage from alcohol addiction: not mine, but my wife’s. It occurred around the same time. She ultimately lost that battle and her life, but only after years of struggles, stints in rehab, and admissions for GI bleeding and liver failure. I was left divorced and a single dad. The stress of the constant combat with active alcoholism led me to leave the partnership of the cardiology practice that I had started, and go off of night call. I calmed the sleepless nights with medications.

Soon I could not sleep without taking a pill. I tried other medications like Lunesta, which I stopped because everything the next day tasted like tin. And then there was Ambien, which I tried after I re-married, but stopped because while “asleep” my wife said I threw my iPad at her. Lastly, there was Belasomra, which didn’t work.

Years went past, and doctors kept on prescribing the lorazepam for me. Finally last year, my sleep doctor (I have obstructive sleep apnea) said I should get off of the benzo’s because recent studies had shown it linked to Alzheimer’s disease in the elderly. After three months of slow weaning, I took my last dose two weeks ago.

Benzodiazepine addiction is real, and withdrawal has been described as more difficult than opiates. I was not on a large dose, one milligram every night, but I was on it for a very long time. I had the classic signs of “therapeutic dose dependence” — tolerance and need for higher doses to be effective, which I did not succumb to. Thus I was more dependent that addicted, which basically is two sides of the same coin. However, after reaching 65, I am not as sharp as I used to be, and when I heard about the benzo-dementia connection, I knew I had to act.

How common is this problem? The short answer is “very.” In 2008, approximately 5.2 percent of U.S. adults aged 18 to 80 years used benzodiazepines. The percentage who used benzodiazepines increased with age from 2.6 percent (18to 35 years) to 5.4 percent (36 to 50 years) to 7.4 percent (51 to 64 years) to 8.7 percent (65 to 80 years).

Benzodiazepine use was nearly twice as prevalent in women as men. In all age groups, roughly one-quarter of individuals receiving benzodiazepine involved long-acting benzodiazepine use. And a study in JAMA Psychiatry in early 2015 reports that among 65 to 80-year-old Americans; close to 9 percent use one of the following hypnotic drugs: Valium, Xanax, Ativan, and Klonopin.

During a work-up of memory loss, confusion, or possible dementia, every physician needs to take a careful drug history with attention to benzo abuse. It is far too easy to get these medications repeatedly refilled by multiple prescribers. It is easy to misdiagnose benzo dependence/addiction symptoms as organic forms of cognitive disorders. In fact in 2012, the American Geriatrics Society updated its list of inappropriate medications for older patients and advised doctors to “avoid benzodiazepines for treatment of insomnia, agitation, or delirium.” The strength of the recommendation was “strong.”

I developed withdrawal anxiety, insomnia, headaches, muscle aches, and had forewarned my wife that I would likely be more irritable than usual. I now take a naturopathic medication that contains melatonin; however, I am not sure that it is any better than placebo. Being completely retired from active practice, it is easier to adapt my lifestyle to my sleep disorder. One thing I know for sure is that I never want to go back on these medications ever again. In the words of Patrick J. Kennedy, “No one is immune from addiction; it affects people of all ages, races, classes, and professions.”

David Mokotoff is a cardiologist who blogs at his self-titled site, David Mokotoff.  He is the author of The Moose’s Children: A Memoir of Betrayal, Death, and Survival and can be reached on Twitter @FreeMarketdoc.

Image credit: Shutterstock.com

Prev

Sage advice to new medical residents

July 24, 2016 Kevin 3
…
Next

What does the opioid crisis have to do with patient satisfaction?

July 25, 2016 Kevin 5
…

Tagged as: Medications

Post navigation

< Previous Post
Sage advice to new medical residents
Next Post >
What does the opioid crisis have to do with patient satisfaction?

ADVERTISEMENT

More by David Mokotoff, MD

  • How tunnel vision can lead to bad medicine

    David Mokotoff, MD
  • Why doctors don’t like to retire

    David Mokotoff, MD
  • The unscientific lure of antibiotics

    David Mokotoff, MD

Related Posts

  • A physician’s addiction to social media

    Amanda Xi, MD
  • Why social media may be causing real emotional harm

    Edwin Leap, MD
  • A physician shares her positive experience with social media

    Claudine J. Aguilera, MD
  • The story of how this physician started her blog

    Sasha K. Shillcutt, MD
  • Why everyone needs a six-word story

    Alexie Puran, MD
  • How a physician keynote can highlight your conference

    Kevin Pho, MD

More in Meds

  • How India-Pakistan tensions could break America’s generic drug pipeline

    Adwait Chafale
  • The unfair war on buprenorphine

    Brian Lynch, MD
  • Drug giants face suit over hidden cancer risks

    Martha Rosenberg
  • The diseconomics of scale: How Indian pharma’s race to scale backfires on U.S. patients

    Adwait Chafale
  • A psychiatrist’s 20-year journey with ketamine

    Muhamad Aly Rifai, MD
  • How drug companies profit by inventing diseases

    Martha Rosenberg
  • Most Popular

  • Past Week

    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • Why medicine needs a second Flexner Report

      Robert C. Smith, MD | Physician
    • A lawyer’s guide to physician side gigs

      Contract Diagnostics | Policy
    • How physicians can turn criticism into collaboration for better teamwork [PODCAST]

      The Podcast by KevinMD | Podcast
    • AI in your health care: a double-edged digital disruptor

      Alan P. Feren, MD | Tech
    • Inside the exam room: anxiety, trust, and medicine

      Michele Luckenbaugh | Conditions
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why doctors must fight for a just health care system

      Alankrita Olson, MD, MPH & Ashley Duhon, MD & Toby Terwilliger, MD | Policy
    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • Why palliative care is more than just end-of-life support

      Dr. Vishal Parackal | Conditions
    • Why medical notes have become billing scripts instead of patient stories

      Sriman Swarup, MD, MBA | Tech
  • Recent Posts

    • AI in your health care: a double-edged digital disruptor

      Alan P. Feren, MD | Tech
    • The crisis of antisemitism in our hospitals

      Carrie Friedman, NP | Policy
    • Why the future of AI in medicine is patient-facing

      Colin Son, MD | Tech
    • Why mild and female hemophilia must be recognized

      Akshat Jain, MD | Conditions
    • Crypto trading’s impact on mental and physical health

      Dr. Aristomenis Exadaktylos, Dr. Suhaib J. S. Ahmad, and Dr. Thomas Mueller | Conditions
    • Why nurse-initiated sepsis protocols are transforming patient care and hospital efficiency [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 9 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • Why medicine needs a second Flexner Report

      Robert C. Smith, MD | Physician
    • A lawyer’s guide to physician side gigs

      Contract Diagnostics | Policy
    • How physicians can turn criticism into collaboration for better teamwork [PODCAST]

      The Podcast by KevinMD | Podcast
    • AI in your health care: a double-edged digital disruptor

      Alan P. Feren, MD | Tech
    • Inside the exam room: anxiety, trust, and medicine

      Michele Luckenbaugh | Conditions
  • Past 6 Months

    • Health equity in Inland Southern California requires urgent action

      Vishruth Nagam | Policy
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why doctors must fight for a just health care system

      Alankrita Olson, MD, MPH & Ashley Duhon, MD & Toby Terwilliger, MD | Policy
    • The ignored clinical trials on statins and mortality

      Larry Kaskel, MD | Conditions
    • Why palliative care is more than just end-of-life support

      Dr. Vishal Parackal | Conditions
    • Why medical notes have become billing scripts instead of patient stories

      Sriman Swarup, MD, MBA | Tech
  • Recent Posts

    • AI in your health care: a double-edged digital disruptor

      Alan P. Feren, MD | Tech
    • The crisis of antisemitism in our hospitals

      Carrie Friedman, NP | Policy
    • Why the future of AI in medicine is patient-facing

      Colin Son, MD | Tech
    • Why mild and female hemophilia must be recognized

      Akshat Jain, MD | Conditions
    • Crypto trading’s impact on mental and physical health

      Dr. Aristomenis Exadaktylos, Dr. Suhaib J. S. Ahmad, and Dr. Thomas Mueller | Conditions
    • Why nurse-initiated sepsis protocols are transforming patient care and hospital efficiency [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Benzodiazepine addiction is real. This physician shares his story.
9 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...